Navigation Links
Hormone Could Improve Diabetes Treatment
Date:6/25/2009

Biomarker might predict how type 2 patients will respond to drugs, study shows

THURSDAY, June 25 (HealthDay News) -- A hormone might be an effective biomarker to help improve treatment of type 2 diabetes, U.S. researchers report.

Adiponectin is a metabolic hormone that regulates a number of processes, including glucose regulation and metabolism of fat for energy production. Previous research has shown an association between adiponectin and insulin sensitivity.

This new study found that levels of the hormone in patients with type 2 diabetes helped predict how patients responded to certain diabetes drugs. The researchers' analysis of data from several clinical trials revealed that levels of adiponectin in the blood are able to predict activation of receptors called PPARs, which assist the genes that help cells respond to insulin.

The results support the possible use of adiponectin as a biomarker to monitor glucose tolerance and to predict patient response to diabetes drugs called thiazolidinediones.

The study appears in the June 24 online edition of Clinical Pharmacology & Therapeutics.

More information

The U.S. National Institute of Diabetes and Digestive Diseases has more about diabetes.



-- Robert Preidt



SOURCE: Clinical Pharmacology & Therapeutics, news release, June 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Appetite-stimulating hormone is first potential medical treatment for frailty in older women
2. MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™
3. Longer Hormone Treatment May Improve Prostate Cancer Outlook
4. Hormone therapy may confer more aggressive properties to prostate tumors
5. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
6. Fighting "Brain Fog": How the Right Hormones Can Improve Mental Sharpness for Women
7. What You Need to Know in Your 40s to Have a Healthy Menopause -- Without Hormone Replacement Therapy
8. Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat
9. A stronger backbone: DHEA hormone replacement increases bone density in older women
10. Womens International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy
11. Test for hormones in blood not reflective of hormones in breast tissue; breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Could Improve Diabetes Treatment 
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending ... the unique opportunity to get hands-on experience in an emergency medical simulation, When ... experience to gain invaluable, real-life medical skills that are critical success in a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... up with a schizophrenic mother in a unique, personal perspective through animation. ... treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
(Date:12/7/2016)... ... 2016 , ... Levels of a protein in the blood associated with heart ... in the journal Radiology. , Heart disease and brain disease exact a major burden ... aging population. Damage to both organs often occurs at a subclinical stage, or before ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
(Date:12/7/2016)... 2016 The global  blood ... of USD 3.9 billion by 2024, based on ... The growth of the market is attributed to ... advancements by the market players. Demand for blood ... donation, rising awareness about transfusion-transmitted diseases, and technological ...
(Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
Breaking Medicine Technology: